Alterations of lymphocyte count and platelet volume precede cerebrovascular lesions in stroke-prone spontaneously hypertensive rats. 2020

Takashi Nishinaka, and Yui Yamazaki, and Atsuko Niwa, and Hidenori Wake, and Shuji Mori, and Tadashi Yoshino, and Masahiro Nishibori, and Hideo Takahashi
Department of Pharmacology, Faculty of Medicine, Kindai University, Osaka, Japan.

Background: Cerebral small vessel disease (CSVD) is associated with future stroke. Although pathological alteration in small vessels of patients with CSVD can be detected by neuroimaging, diagnosis of CSVD is delayed because it is an asymptomatic disease. The stroke-prone spontaneously hypertensive rat (SHRSP) show similar pathological features to human CSVD and develop stroke-related symptoms with advancing age.Objective: We investigated the time course of haematological parameters in Wistar rats and SHRSP.Material and Methods: Blood cells were analysed using an automated haematological analyser.Results: SHRSP develop stroke-related symptoms including onset of neurological symptoms, decreased body weight and blood brain barrier leakage between 12 and 14 weeks of age. Lymphocyte counts were gradually decreased at 3 weeks before development of stoke-related symptoms and then were further decreased after the development of stroke-related symptoms. The both mean platelet volume and large platelet ratio gradually increased at 3 weeks before the development of stoke-related symptoms. However, although SHRSP showed more microcytic red cells than Wistar rats, the trajectories of change in erythrocyte-related parameters were similar between Wistar rats and SHRSP.Conclusion: Our pilot study suggests that alterations of lymphocyte count and platelet volume predictive indicators for asymptomatic CSVD and symptomatic stroke in SHRSP.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D010865 Pilot Projects Small-scale tests of methods and procedures to be used on a larger scale if the pilot study demonstrates that these methods and procedures can work. Pilot Studies,Pilot Study,Pilot Project,Project, Pilot,Projects, Pilot,Studies, Pilot,Study, Pilot
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D011918 Rats, Inbred SHR A strain of Rattus norvegicus with elevated blood pressure used as a model for studying hypertension and stroke. Rats, Spontaneously Hypertensive,Rats, SHR,Inbred SHR Rat,Inbred SHR Rats,Rat, Inbred SHR,Rat, SHR,Rat, Spontaneously Hypertensive,SHR Rat,SHR Rat, Inbred,SHR Rats,SHR Rats, Inbred,Spontaneously Hypertensive Rat,Spontaneously Hypertensive Rats
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D013045 Species Specificity The restriction of a characteristic behavior, anatomical structure or physical system, such as immune response; metabolic response, or gene or gene variant to the members of one species. It refers to that property which differentiates one species from another but it is also used for phylogenetic levels higher or lower than the species. Species Specificities,Specificities, Species,Specificity, Species

Related Publications

Takashi Nishinaka, and Yui Yamazaki, and Atsuko Niwa, and Hidenori Wake, and Shuji Mori, and Tadashi Yoshino, and Masahiro Nishibori, and Hideo Takahashi
January 1985, Acta neuropathologica,
Takashi Nishinaka, and Yui Yamazaki, and Atsuko Niwa, and Hidenori Wake, and Shuji Mori, and Tadashi Yoshino, and Masahiro Nishibori, and Hideo Takahashi
July 1978, Japanese heart journal,
Takashi Nishinaka, and Yui Yamazaki, and Atsuko Niwa, and Hidenori Wake, and Shuji Mori, and Tadashi Yoshino, and Masahiro Nishibori, and Hideo Takahashi
June 1978, Experimental and molecular pathology,
Takashi Nishinaka, and Yui Yamazaki, and Atsuko Niwa, and Hidenori Wake, and Shuji Mori, and Tadashi Yoshino, and Masahiro Nishibori, and Hideo Takahashi
March 1990, Journal of applied physiology (Bethesda, Md. : 1985),
Takashi Nishinaka, and Yui Yamazaki, and Atsuko Niwa, and Hidenori Wake, and Shuji Mori, and Tadashi Yoshino, and Masahiro Nishibori, and Hideo Takahashi
January 1982, Iyo Kizai Kenkyujo hokoku. Reports of the Institute for Medical and Dental Engineering, Tokyo Medical and Dental University,
Takashi Nishinaka, and Yui Yamazaki, and Atsuko Niwa, and Hidenori Wake, and Shuji Mori, and Tadashi Yoshino, and Masahiro Nishibori, and Hideo Takahashi
January 1983, Clinical and experimental neurology,
Takashi Nishinaka, and Yui Yamazaki, and Atsuko Niwa, and Hidenori Wake, and Shuji Mori, and Tadashi Yoshino, and Masahiro Nishibori, and Hideo Takahashi
May 1989, Archives of gerontology and geriatrics,
Takashi Nishinaka, and Yui Yamazaki, and Atsuko Niwa, and Hidenori Wake, and Shuji Mori, and Tadashi Yoshino, and Masahiro Nishibori, and Hideo Takahashi
March 2017, Physiological genomics,
Takashi Nishinaka, and Yui Yamazaki, and Atsuko Niwa, and Hidenori Wake, and Shuji Mori, and Tadashi Yoshino, and Masahiro Nishibori, and Hideo Takahashi
January 1976, Stroke,
Takashi Nishinaka, and Yui Yamazaki, and Atsuko Niwa, and Hidenori Wake, and Shuji Mori, and Tadashi Yoshino, and Masahiro Nishibori, and Hideo Takahashi
July 1999, Japanese journal of pharmacology,
Copied contents to your clipboard!